- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 22.79M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $58.67M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $57.9M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $2.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $4.23M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $37.77M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $35.86M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $105.5M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $101.26M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $20.4M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $19.6M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $135.18M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $132.54M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 23.96M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $15M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $2.91M |
| Capex | Q1 2025 · Mar 31, 2024 | $4.14M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $12.04M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $36.95M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $48.96M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.27 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.27 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $11.25M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $8.76M |
| Revenue | Q1 2025 · Mar 31, 2024 | $35.31M |